Citations

Showing 10 of 108152 citations.

Outcomes and Complications of Pediatric Cranioplasty: A Systematic Review
Banuelos, Joseph, Oliver, Jeremie D. , Vyas, Krishna S. , Daniels, David N., Sharaf, Basel , Abu-Ghname, Amjed, Oliver, Jeremie D , Abu‐Ghname, Amjed , Daniels, David, Sharaf, Basel A

Mayo Clinic

Plastic & Reconstructive Surgery | August 28, 2019 | Volume: 144 | Issue: 3 | Pages: 433e-443e

10.1097/prs.0000000000005933 | PMID 31461029 Get It

Background: Pediatric calvarial reconstruction is challenging because of the unique anatomical and growth considerations in this population. Comparative studies evaluating current cranioplasty materials are lacking. This review addresses the knowledge gap in pediatric cranioplasty outcomes with emphasis on current materials used. Methods: A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Outcome data comparing fresh bone, banked bone, titanium, poly(methyl methacrylate), and polyetheretherketone were abstracted. Results: Twenty studies met the authors’ selection criteria. The mean patient age ranged from 4 to 17.4 years. Autologous cranioplasty was performed in 439 patients, and 201 patients underwent alloplastic reconstruction. Fresh bone grafts and titanium mesh were associated with the lowest infection rates (0.4 percent and 3.3 percent, respectively; p < 0.001), graft failures (2.9 percent and 3.3 percent, respectively; p < 0.001), and surgical-site occurrence rates (8.8 percent and 6.7 percent, respectively; p < 0.001). Banked bone flaps had the highest overall complication rates (51 percent; p < 0.001), bone resorption (39.7 percent; p < 0.001), and failure rates (40.2 percent; p < 0.001), whereas polyetherether ketone had the highest rates of infection (16.1 percent; p < 0.001). Conclusions: Based on the available evidence to date, fresh bone grafts and titanium mesh demonstrated the lowest surgical-site infection, surgical-site occurrence, and graft failure rates. Banked bone flaps had the highest overall surgical-site complications and graft failures. Pediatric cranioplasty outcomes studies are needed to evaluate current and novel cranioplasty materials.
Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids
Marzano, Mark, Bejoy, Julie , Cheerathodi, Mujeeb R., Sun, Li , York, Sara B. , Kanekiyo, Takahisa , Bu, Guojun , Meckes, David G. , Meckes, David G , Bu, Guojun , Zhao, Jing , Li, Yan , Sun, Li

Mayo Clinic

Cells | August 28, 2019 | Volume: 8 | Issue: 9 | Pages: 993

10.3390/cells8090993 | PMID 31466320 Get It

Extracellular vesicles (EVs) contribute to a variety of signaling processes and the overall physiological and pathological states of stem cells and tissues. Human induced pluripotent stem cells (hiPSCs) have unique characteristics that can mimic embryonic tissue development. There is growing interest in the use of EVs derived from hiPSCs as therapeutics, biomarkers, and drug delivery vehicles. However, little is known about the characteristics of EVs secreted by hiPSCs and paracrine signaling during tissue morphogenesis and lineage specification. Methods: In this study, the physical and biological properties of EVs isolated from hiPSC-derived neural progenitors (ectoderm), hiPSC-derived cardiac cells (mesoderm), and the undifferentiated hiPSCs (healthy iPSK3 and Alzheimer’s-associated SY-UBH lines) were analyzed. Results: Nanoparticle tracking analysis and electron microscopy results indicate that hiPSC-derived EVs have an average size of 100–250 nm. Immunoblot analyses confirmed the enrichment of exosomal markers Alix, CD63, TSG101, and Hsc70 in the purified EV preparations. MicroRNAs including miR-133, miR-155, miR-221, and miR-34a were differently expressed in the EVs isolated from distinct hiPSC lineages. Treatment of cortical spheroids with hiPSC-EVs in vitro resulted in enhanced cell proliferation (indicated by BrdU+ cells) and axonal growth (indicated by β-tubulin III staining). Furthermore, hiPSC-derived EVs exhibited neural protective abilities in Aβ42 oligomer-treated cultures, enhancing cell viability and reducing oxidative stress. Our results demonstrate that the paracrine signaling provided by tissue context-dependent EVs derived from hiPSCs elicit distinct responses to impact the physiological state of cortical spheroids. Overall, this study advances our understanding of cell‒cell communication in the stem cell microenvironment and provides possible therapeutic options for treating neural degeneration.
The positive predictive value of genetic screening tests
Hagenkord, Jill , Funke, Birgit , Hegde, Madhuri , Ferber, Matthew J. , Lebo, Matthew S. , Buchanan, Adam H. , Bick, David , Qian, Emily , Jacobs, Kevin B. , Lebo, Matthew

Mayo Clinic

No container title available | August 28, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7287/peerj.preprints.27922v1 Get It

As the cost of DNA sequencing continues to fall, more individuals are opting to undergo genomic testing in the absence of a clinical indication. Testing asymptomatic individuals for unsuspected conditions is not new to the medical and public health communities. However, the application of screening principles to inherited diseases with unknown prevalence in an unselected (low-risk) test population raises unique challenges. This paper examines the effect of disease prevalence on the positive predictive value of a test result. Many inherited conditions have very low prevalence in an unselected population, which increases the probability that some likely pathogenic variants may be false positives. In situations where the adverse impact of a false positive result is significant, laboratories should address this issue by either increasing the interpretive specificity of the test, performing a clinical confirmatory test to establish the presence of disease, or restricting the test to a population with increased disease prevalence. Here, we review the statistical concepts relevant to screening tests, apply these concepts to genetic disease screening, create a model to estimate prevalence and positive predictive value, and provide a framework for further discussion.
Team Approach: Role of Medical and Surgical Management in Rheumatoid Arthritis of the Hand and Wrist
O’Shaughnessy, Maureen , Kannas, Stephanie , Ernste, Floranne C. , Rizzo, Marco , O'Shaughnessy, Maureen A, Ernste, Floranne

Mayo Clinic

JBJS Reviews | August 28, 2019 | Volume: 7 | Issue: 8 | Pages: e10-e10

10.2106/jbjs.rvw.18.00196 | PMID 31460989 Get It

» Treatment of the patient with rheumatoid arthritis affecting the hand and wrist can be a challenging endeavor. Optimal management for best outcomes includes careful collaboration between providers managing the medical treatment of the disease, therapists, hand surgeons, and the patient. » In this review, we present a challenging clinical scenario with input from key voices from various medical fields to provide a balanced and unbiased diagnosis and treatment recommendation for a patient with complex rheumatoid pathology affecting her hand and wrist.
Multi‐institutional analysis of outcomes following transoral surgery for HPV‐positive oropharyngeal squamous cell carcinoma in elderly patients
Jackson, Ryan S. , Chen, Stephanie , Last, Aisling, Khan, Amish M., Kallogjeri, Dorina , Abel, Kathryn M. Van , Moore, Eric J. , Pipkorn, Patrik , Van Abel, Kathryn M

Mayo Clinic

Head & Neck | August 28, 2019 | Volume: 41 | Issue: 11 | Pages: 3933-3939

10.1002/hed.25946 | PMID 31460691 Get It

AbstractBackgroundThe incidence of human papillomavirus (HPV)‐related oropharyngeal squamous cell carcinoma (OPSCC) is rising, even in elderly patients. The outcomes of transoral surgery (TOS) in this population are not entirely known.MethodsA retrospective review was performed at two institutions from October 2003 to September 2016 on patients 70 years or older with HPV‐related OPSCC treated with TOS.ResultsA total of 75 patients were included with a mean age of 74 years (70‐87 years). At a median follow‐up of 35.7 months, 3‐year overall survival was 81.5% and disease‐specific survival was 94.3%. Advanced cT stage (odds ratio, 2.74; 95% confidence interval, 1.13‐6.64) negatively impacted OS. Conjunctive consolidation was performed to create a staging system with patients older than 80 years, severe comorbidity, and cT3‐4 having worse survival.ConclusionsElderly patients with HPV‐related OPSCC treated with TOS have excellent survival and therefore should not be excluded from such therapy based on age alone.
What’s in the pipeline for lower functional gastrointestinal disorders in the next 5 years?
Camilleri, Michael

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | August 28, 2019 | Volume: 317 | Issue: 5 | Pages: G640-G650

10.1152/ajpgi.00205.2019 | PMID 31460793 Get It

The overall objectives of this review are to summarize actionable biomarkers for organic etiology of lower functional gastrointestinal disorders (FGIDs) that lead to individualized treatment for their FGIDs and to assess the pipeline for novel approaches to the management of constipation, diarrhea, and chronic abdominal pain in lower FGIDs. The new approaches to therapy include ion exchangers/transporters for functional constipation (sodium-glucose cotransporter 1, Na+/H+ exchanger 3, and solute carrier family 26 member 3 inhibitors), bile acid modulators for constipation such as ileal bile acid transporter inhibitors and fibroblast growth factor 19 analog for functional constipation, and bile acid sequestrants or farnesoid X receptor agonists for functional diarrhea. Treatment for chronic abdominal pain remains an unmet need in patients with lower FGIDs, and promising novel approaches include delayed-release linaclotide, nonclassical opioid visceral analgesics, and selective cannabinoid receptor agonists. The role of probiotics, fecal microbial transplantation, and possible future microbiome therapies is discussed.
Segment of posterior tricuspid valve leaflet missing after lead extraction
Naser, Jwan A. , Mulpuru, Siva K. , Aung, Htin , Arghami, Arman , Aung, Htin, Pislaru, Sorin V. , Naser, Jwan A

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | August 28, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ehjci/jez234 | PMID 31642898 Get It

Tendon rupture associated with concomitant simvastatin and gemfibrozil use: Biological and pharmacokinetic implications
Cevallos, Edison Cano , Shaikh, Danial , González, José R., Sanchez, William, Patel, Madanmohan, Cano Cevallos, Edison Jose

Mayo Clinic

Clinical Case Reports | August 28, 2019 | Volume: 7 | Issue: 10 | Pages: 1919-1922

10.1002/ccr3.2387 | PMID 31624609 Get It

Abstract Tendon or muscle rupture is a rare complication of statins that could potentially be disabling and result in a significant burden to patients. The co‐administration of statin and gemfibrozil should warrant prescribers’ awareness of tendon‐related complications of statin use, particularly in high‐risk populations with poor renal function or musculoskeletal comorbidities.
Metabolic disturbances for the electrophysiologist
Lee, Justin Z. , Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | August 28, 2019 | Volume: 30 | Issue: 10 | Pages: 2147-2149

10.1111/jce.14139 | PMID 31456246 Get It

Advances in the therapy of BRAFV600E metastatic colorectal cancer
Jin, Zhaohui , Jin, Zhaohui , Sinicrope, Frank A.

Mayo Clinic

Expert Review of Anticancer Therapy | August 28, 2019 | Volume: 19 | Issue: 9 | Pages: 823-829

10.1080/14737140.2019.1661778 | PMID 31455117 Get It